“We continue to believe in a positive benefit-risk profile of COVID-19 vaccine,” Johnson & Johnson said in response to the statement released after the US CDC Advisory Committee meeting.
more to come ....
Reprinted from FXStreet，the copyright all reserved by the original author.
Disclaimer: The views expressed are solely those of the author and do not represent the official position of Followme. Followme does not take responsibility for the accuracy, completeness, or reliability of the information provided and is not liable for any actions taken based on the content, unless explicitly stated in writing.
Like this article? Show your appreciation by sending a tip to the author.
Leave Your Message Now